Cardizem CD (diltiazem HCl) capsules, 180 mg, packaged in a) 30-count bottles (NDC 0187-0796-30); and b) 90-count bottles (NDC 0187-0796-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.
Published February 20, 2019 · Recall initiated: January 30, 2019
Summary
FDA records drug Class III recall D-0488-2019, published February 20, 2019 and initiated January 30, 2019. Recalling firm: Valeant Pharmaceuticals North America LLC; Status: Terminated; Reported quantity: 206 bottles; Lot: Lots: a) 18J018P, Exp 08/2020; b) 18J029P, Exp 08/2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
What to do
Voluntary: Firm initiated · Letter
Get an email if CARDIZEM CD has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CARDIZEM CD
- Manufacturer
- Valeant Pharmaceuticals North America LLC
- Distributor
- Nationwide in the USA and Puerto Rico
- UPC
- 0301870796421
- Lot
- Lots: a) 18J018P, Exp 08/2020; b) 18J029P, Exp 08/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACardizem CD (diltiazem HCl) capsules, 120 mg, packaged in a) 30-count bottles (NDC 0187-0795-30); and b)February 20, 2019
- FDACardizem CD (diltiazem HCl) capsules, 300 mg, packaged in a) 30-count bottles (NDC 0187-0798-30); and b)February 20, 2019
- FDACOSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle,February 20, 2019
- FDADiltiazem HCl CD capsules, 360 mg, 90-count bottles, Rx Only, Manufactured for: Oceanside Pharmaceuticals, aFebruary 20, 2019
- FDALET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL Single Use Syringe, Rx only,February 20, 2019
- FDAClobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Macleods Pharma USA,February 20, 2019
Questions about this recall
Was Cardizem CD (diltiazem HCl) capsules, 180 mg, packaged in a) 30-count bottles (NDC 0187-0796-30); and b) 90-count bottles (NDC 0187-0796-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada. recalled?
Yes. FDA published recall D-0488-2019 on February 20, 2019. Reported hazard: Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CARDIZEM CD. UPC: 0301870796421.